The relevance of maternal immune responses to inhalant allergens to maternal symptoms, passive transfer to the infant, and development of antibodies in the first 2 years of life.
about
Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.Prenatal negative life events increases cord blood IgE: interactions with dust mite allergen and maternal atopy.Relationships among prenatal aeroallergen exposure and maternal and cord blood IgE: project ACCESS.Asthma and indoor air: contrasts in the dose response to cat and dust-mite.Prenatal, perinatal, and heritable influences on cord blood immune responses.Mode of delivery and cord blood cytokines: a birth cohort study.Maternal transmission of resistance to development of allergic airway diseaseHigher adiposity in infancy associated with recurrent wheeze in a prospective cohort of childrenAssociations among maternal childhood socioeconomic status, cord blood IgE levels, and repeated wheeze in urban childrenPrenatal exposure to household pets influences fetal immunoglobulin E productionMaternal interpersonal trauma and cord blood IgE levels in an inner-city cohort: a life-course perspectiveBreastmilk from allergic mothers can protect offspring from allergic airway inflammation.Effect of household pet ownership on infant immune response and subsequent sensitizationMost of diaplacentally transferred allergen is retained in the placenta.Parental allergic status influences the risk of developing allergic sensitization and an asthmatic-like phenotype in canine offspring.Prenatal exposure to mite and pet allergens and total serum IgE at birth in high-risk children
P2860
Q30276181-60991355-6DA9-43A8-829E-F145EA20A55FQ30420151-63F4341A-D7F6-4B21-B8EB-080D34EFF718Q30436265-CA61EC03-FB85-48C7-A4C7-19AF1600D5B9Q30437016-548532B3-65B2-4CAE-A714-F3D83FA8E4AEQ35021720-2C19A69E-DBFF-4074-94F4-983165B8F7D1Q35069347-AFB5AD62-DD1F-40A4-9215-10C2F5FD89CEQ35163648-B9F96211-5D73-4D9E-82B6-05730FB72830Q35659625-13C939CB-1D3E-403F-A6AF-C7A8A4430EA6Q36670634-E1388452-4824-4F88-956B-CB8E548C7FC0Q37096880-DEAC74EC-622C-45A4-B1BA-3800A63EB43FQ37097737-8EB3CF44-70B0-4481-9D02-A1015EC1E130Q37375460-8D440495-3DFE-41CD-9F20-CCDBFCD3422EQ37857680-F8C31814-91E6-45AF-A20E-8575A8FB785CQ40234050-E9BFFCF4-7825-43CD-8F9B-0CB1FC83DA7DQ44665304-7E032009-69D6-4FC3-B804-5E3923345E15Q57313680-9D8EFD1C-3D4D-4091-BE05-45D6D3001C04
P2860
The relevance of maternal immune responses to inhalant allergens to maternal symptoms, passive transfer to the infant, and development of antibodies in the first 2 years of life.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The relevance of maternal immu ...... in the first 2 years of life.
@ast
The relevance of maternal immu ...... in the first 2 years of life.
@en
type
label
The relevance of maternal immu ...... in the first 2 years of life.
@ast
The relevance of maternal immu ...... in the first 2 years of life.
@en
prefLabel
The relevance of maternal immu ...... in the first 2 years of life.
@ast
The relevance of maternal immu ...... in the first 2 years of life.
@en
P2093
P356
P1476
The relevance of maternal immu ...... in the first 2 years of life.
@en
P2093
Anne B Allison
Diane Gold
Diane Sredl
Elizabeth A Erwin
Harriet Burge
Kevin Blumenthal
Marisa Barr
P304
P356
10.1067/MAI.2003.10
P407
P577
2003-01-01T00:00:00Z